(Total Views: 228)
Posted On: 09/06/2021 6:59:08 AM
Post# of 128064
Study: COVID Shot Enhances Delta Infectivity
STORY AT-A-GLANCE
According to the U.S. Centers for Disease Control and Prevention, people who got the COVID shot early are now at increased risk for severe COVID disease
This may be a sign that antibody dependent enhancement (ADE) is occurring, or it may simply indicate that the protection offered is limited to a few months, at best
Recent research warns the Delta variant “is posed to acquire complete resistance to wild-type spike vaccines.” This could turn into a worst-case scenario that sets up those who have received the Pfizer shots for more severe illness when exposed to the virus
To “stay ahead of the virus,” the Biden administration is now considering recommending a booster shot five months after the initial two doses rather than waiting eight months, as previously suggested
Israeli data show Pfizer’s shot went from a 95% effectiveness at the outset to 39% by late July 2021, when the Delta strain became predominant. The U.S. Food and Drug Administration’s expectation for any vaccine is an efficacy rate of at least 50% compared to placebo
https://articles.mercola.com/sites/articles/a...1256704150
STORY AT-A-GLANCE
According to the U.S. Centers for Disease Control and Prevention, people who got the COVID shot early are now at increased risk for severe COVID disease
This may be a sign that antibody dependent enhancement (ADE) is occurring, or it may simply indicate that the protection offered is limited to a few months, at best
Recent research warns the Delta variant “is posed to acquire complete resistance to wild-type spike vaccines.” This could turn into a worst-case scenario that sets up those who have received the Pfizer shots for more severe illness when exposed to the virus
To “stay ahead of the virus,” the Biden administration is now considering recommending a booster shot five months after the initial two doses rather than waiting eight months, as previously suggested
Israeli data show Pfizer’s shot went from a 95% effectiveness at the outset to 39% by late July 2021, when the Delta strain became predominant. The U.S. Food and Drug Administration’s expectation for any vaccine is an efficacy rate of at least 50% compared to placebo
https://articles.mercola.com/sites/articles/a...1256704150
(0)
(0)
